Staff at the Queen Elizabeth Hospital in King’s Lynn are looking for patients to take part in a pioneering aspirin trial.
The research is part of a national five-year study to see if taking aspirin on a regular basis could help to prevent certain types of cancer from returning.
The study has been sponsored by University College London and staff have said they are excited to be included.
Since launching in April, staff at the hospital’s Macmillan Cancer Unit along with the Research and Development Team, have started to work with 13 patients and they hope to sign-up many more.
Dr Nicola Ainsworth, the hospital’s principal investigator, said: “It is a very exciting trial to be involved with. If a simple drug can reduce the chances of a cancer returning then this work can have a huge impact on the lives of future patients.”
The trial will focus on patients who are or have been treated for breast, bowel, prostate, stomach and oesophageal cancer.
The aim will be to recruit 9,920 patients nationally. The trial will be over five years and will involve patients taking aspirin and a placebo drug.
Some hospital visits will be necessary for check-ups, but later sessions will be conducted by telephone.
QEH senior research nurse Corrine Rankin said staff were grateful to patients for their commitment to the study, which has been funded by Cancer Research and health institutions.
Anyone who would like to be considered for the trial should call Corrine Rankin on 01553 214567.